longbridge

RSPH

----

Merck KGaA Group has agreed to acquire Bio-Techne for $73 per share in cash

Merck KGaA Group has agreed to acquire Bio-Techne for $73 per share in cash.

Source: Wallstreetcn The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

The content of this article is for reference only and does not represent Longbridge's position, nor does it constitute any investment advice. Investment involves risks, please invest cautiously.

© 2026 LongbridgeTerms of ServicePrivacy Policy